OVID stock news
This page provides real-time market news, earnings updates, and company announcements related to Ovid Therapeutics Inc. (OVID).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 15:06 EST
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-18 10:12:46
Financial Data Highlights: Ovid Therapeutics Inc. (NASDAQ: OVID) reported in its latest financial statement that as of December 31, 2025, the company held a total of $90.4 million in cash, cash equivalents, and marketable securities.
老虎证券2026-03-18 10:23:26
Breakthrough in new drug development boosts market confidence: Ovid Therapeutics Inc. (NASDAQ: OVID) shares surged 26.4% in pre-market trading today after the company announced positive safety data for its experimental epilepsy drug OV935/TAK-935.
老虎证券2026-03-18 10:52:38
OVID stock chart
OVID stock detailsOVID stock price change
On the last trading day, OVID stock closed at 2.76 USD, with a price change of -6.76% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more